Payment overview · 2025
General Payments
$287.39
4 reported records · 4 companies
Healthcare provider profile · identity verified
John Joseph Forney, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · CHARLESTON, SC · NPI 1548240559
Verified facts
What the public records show
CMS Open Payments records show John Joseph Forney, M.D. received $287.39 in general payments during 2025 across 4 reported records.
Exact Sciences Corporation accounted for 39.9% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 63 claims for Jardiance by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRULICITY as an associated drug or biological on 71 records involving 57 distinct recipient NPIs. Public Medicare Part D data also shows 59 claims for Trulicity by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $114.63 | 39.9% | 1 | 2025 |
| Lilly USA, LLC | Unresolved — no canonical attribution shown | $80.19 | 27.9% | 1 | 2025 |
| Averitas Pharma Inc. | Unresolved — no canonical attribution shown | $68.82 | 23.9% | 1 | 2025 |
| Baxter Healthcare | Unresolved — no canonical attribution shown | $23.75 | 8.3% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $287.39 | 4 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| The Cologuard Plus Collection Kit Normalized: the cologuard plus collection kit |
Device | Exact Sciences Corporation | $114.63 | 1 | 2025 |
Source payment records
|
|||||
| QUTENZA Normalized: qutenza |
Drug | Averitas Pharma Inc. | $68.82 | 1 | 2025 |
Source payment records
|
|||||
| Hillrom - RetinaVue 700 Imager Normalized: hillrom retinavue 700 imager |
Device | Baxter Healthcare | $23.75 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
63 | 16 |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | TRULICITY open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 57 recipient NPIs · example record 1186464601 |
Trulicity · 2024 Exact normalized brand match · 1 Part D row |
59 | 12 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 952 | 167 |
| Amlodipine Besylate | Amlodipine Besylate | 844 | 144 |
| Levothyroxine Sodium | Levothyroxine Sodium | 611 | 105 |
| Quetiapine Fumarate | Quetiapine Fumarate | 398 | 81 |
| Omeprazole | Omeprazole | 360 | 82 |
| Famotidine | Famotidine | 356 | 67 |
| Escitalopram Oxalate | Escitalopram Oxalate | 351 | 84 |
| Lisinopril | Lisinopril | 347 | 59 |
| Losartan Potassium | Losartan Potassium | 316 | 57 |
| Furosemide | Furosemide | 291 | 70 |
| Metoprolol Succinate | Metoprolol Succinate | 268 | 43 |
| Eliquis | Apixaban | 264 | 48 |
| Donepezil Hcl | Donepezil Hcl | 259 | 54 |
| Metformin Hcl | Metformin Hcl | 241 | 42 |
| Trazodone Hcl | Trazodone Hcl | 235 | 49 |
| Sertraline Hcl | Sertraline Hcl | 213 | 37 |
| Tamsulosin Hcl | Tamsulosin Hcl | 206 | 47 |
| Olanzapine | Olanzapine | 197 | 23 |
| Fluticasone Propionate | Fluticasone Propionate | 187 | 51 |
| Potassium Chloride | Potassium Chloride | 187 | 41 |
| Simvastatin | Simvastatin | 177 | 25 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 175 | 30 |
| Memantine Hcl | Memantine Hcl | 171 | 30 |
| Fluoxetine Hcl | Fluoxetine Hcl | 163 | 19 |
| Mirtazapine | Mirtazapine | 162 | 32 |
| Pantoprazole Sodium | Pantoprazole Sodium | 162 | 36 |
| Gabapentin | Gabapentin | 145 | 42 |
| Hydrochlorothiazide | Hydrochlorothiazide | 134 | 29 |
| Lorazepam | Lorazepam | 134 | 38 |
| Myrbetriq | Mirabegron | 129 | 19 |
| Metoprolol Tartrate | Metoprolol Tartrate | 126 | 32 |
| Duloxetine Hcl | Duloxetine Hcl | 121 | 32 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 118 | 42 |
| Benztropine Mesylate | Benztropine Mesylate | 117 | 21 |
| Levetiracetam | Levetiracetam | 111 | 18 |
| Carvedilol | Carvedilol | 110 | 29 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 97 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 94 | 17 |
| Pravastatin Sodium | Pravastatin Sodium | 93 | 21 |
| Citalopram Hbr | Citalopram Hydrobromide | 92 | 18 |
| Clopidogrel | Clopidogrel Bisulfate | 90 | 22 |
| Tramadol Hcl | Tramadol Hcl | 85 | 38 |
| Risperidone | Risperidone | 82 | 14 |
| Spironolactone | Spironolactone | 81 | 14 |
| Finasteride | Finasteride | 77 | 14 |
| Loperamide | Loperamide Hcl | 76 | 24 |
| Buspirone Hcl | Buspirone Hcl | 73 | 15 |
| Allopurinol | Allopurinol | 72 | 13 |
| Alprazolam | Alprazolam | 71 | 25 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 71 | 11 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 69 | 59 |
| Alendronate Sodium | Alendronate Sodium | 66 | 15 |
| Jardiance | Empagliflozin | 63 | 16 |
| Glipizide Er | Glipizide | 62 | 14 |
| Valsartan | Valsartan | 61 | suppressed |
| Trulicity | Dulaglutide | 59 | 12 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 58 | 20 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 53 | suppressed |
| Azithromycin | Azithromycin | 52 | 46 |
| Farxiga | Dapagliflozin Propanediol | 52 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 52 | 18 |
| Ketoconazole | Ketoconazole | 51 | 22 |
| Atenolol | Atenolol | 50 | suppressed |
| Olanzapine Odt | Olanzapine | 50 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 42 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 41 | suppressed |
| Baclofen | Baclofen | 39 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 38 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 38 | suppressed |
| Meloxicam | Meloxicam | 38 | 11 |
| Prednisone | Prednisone | 38 | 15 |
| Naproxen | Naproxen | 37 | 17 |
| Oxycodone Hcl | Oxycodone Hcl | 37 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 36 | 11 |
| Divalproex Sodium Er | Divalproex Sodium | 34 | suppressed |
| Januvia | Sitagliptin Phosphate | 34 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 33 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 33 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 32 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 32 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 31 | 25 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 30 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 30 | suppressed |
| Fluphenazine Hcl | Fluphenazine Hcl | 29 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 29 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 28 | suppressed |
| Desmopressin Acetate | Desmopressin Acetate | 28 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 28 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 27 | 20 |
| Haloperidol | Haloperidol | 27 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 27 | 12 |
| Ropinirole Hcl | Ropinirole Hcl | 27 | suppressed |
| Xarelto | Rivaroxaban | 27 | suppressed |
| Celecoxib | Celecoxib | 26 | suppressed |
| Glipizide | Glipizide | 26 | suppressed |
| Methotrexate | Methotrexate Sodium | 26 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 25 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 25 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 24 | suppressed |
| Lamotrigine | Lamotrigine | 24 | suppressed |
| Lidocaine | Lidocaine | 24 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 24 | 20 |
| Paroxetine Hcl | Paroxetine Hcl | 24 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 24 | suppressed |
| Clonazepam | Clonazepam | 23 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 23 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 23 | 16 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 22 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 22 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 22 | suppressed |
| Nystatin | Nystatin | 22 | 13 |
| Ozempic | Semaglutide | 22 | suppressed |
| Latanoprost | Latanoprost | 21 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 21 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 20 | suppressed |
| Ranolazine Er | Ranolazine | 20 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 20 | 12 |
| Verapamil Sr | Verapamil Hcl | 20 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 19 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 18 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 18 | suppressed |
| Primidone | Primidone | 18 | suppressed |
| Amantadine | Amantadine Hcl | 17 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 17 | suppressed |
| Digoxin | Digoxin | 17 | suppressed |
| Ezetimibe | Ezetimibe | 17 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 17 | suppressed |
| Methimazole | Methimazole | 17 | suppressed |
| Ondansetron Odt | Ondansetron | 17 | 12 |
| Raloxifene Hcl | Raloxifene Hcl | 17 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 16 | suppressed |
| Bumetanide | Bumetanide | 16 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 16 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 16 | suppressed |
| Pregabalin | Pregabalin | 15 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 15 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 14 | 12 |
| Fentanyl | Fentanyl | 14 | suppressed |
| Lamotrigine Odt | Lamotrigine | 14 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 14 | suppressed |
| Roflumilast | Roflumilast | 14 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 14 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 14 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 14 | suppressed |
| Aripiprazole | Aripiprazole | 13 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 13 | suppressed |
| Cephalexin | Cephalexin | 13 | suppressed |
| Ezetimibe-Simvastatin | Ezetimibe/Simvastatin | 13 | suppressed |
| Linzess | Linaclotide | 13 | suppressed |
| Lovastatin | Lovastatin | 13 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 13 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 13 | suppressed |
| Sucralfate | Sucralfate | 13 | suppressed |
| Tirosint | Levothyroxine Sodium | 13 | suppressed |
| Valproic Acid | Valproic Acid | 13 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 12 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 12 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 12 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 12 | suppressed |
| Topiramate | Topiramate | 12 | suppressed |
| Tradjenta | Linagliptin | 12 | suppressed |
| Diazepam | Diazepam | 11 | suppressed |
| Donepezil Hcl Odt | Donepezil Hcl | 11 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 11 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 11 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 11 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 11 | suppressed |
| Klor-Con M20 | Potassium Chloride | 11 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 11 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 11 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 11 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $287.39 · 4 records | Exact Sciences Corporation | Hillrom - RetinaVue 700 Imager, QUTENZA, The Cologuard Plus Collection Kit | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with Lilly USA, LLC?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error